Yuan Xu
CIK 1858214 · last filed 2025-12-09
Yuan Xu is a corporate insider who has filed 20 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for AKRO, was dated Dec 9, 2025. Across all open-market trades the lifetime net is −$24.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$17.9K
3
20
-$24.3K
Holdings By Company
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Disp (D) | −9,398 | $0 | EDGAR |
| 2025-06-12 | XLO | Grant (A) | — | $0 | EDGAR |
| 2025-06-05 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +9,398 | $0 | EDGAR |
| 2025-05-30 | FATE | Grant (A) | — | $0 | EDGAR |
| 2024-08-07 | FATE | Sell (S) | −633 | -$2.7K | EDGAR |
| 2024-06-17 | XLO | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | FATE | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-07 | FATE | Sell (S) | −632 | -$2.3K | EDGAR |
| 2023-06-27 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |